Skip to main content
. 2021 Aug 9;22(16):8573. doi: 10.3390/ijms22168573

Figure 3.

Figure 3

The log-probit dose–response relationship lines for CAM and CDDP in MCF7, T47D, MDA-MB-231, and MDA-MB-468 cell lines. (A) Log-probit dose–response relationship lines for CAM and CDDP administered alone and in combination at the fixed-ratio of 1:1, with respect to their anti-proliferative effects on the MCF7 cell lines. (B) Log-probit dose–response relationship lines for CAM and CDDP administered alone and in combination at the fixed-ratio of 1:1, with respect to their anti-proliferative effects on the T47D cell lines. (C) Log-probit dose–response relationship lines for CAM and CDDP administered alone and in combination at the fixed-ratio of 1:1, with respect to their anti-proliferative effects on the MDA-MB-231 cell lines. (D) Log-probit dose–response relationship lines for CAM and CDDP administered alone and in combination at the fixed-ratio of 1:1, with respect to their anti-proliferative effects on the MDA-MB-468 cell lines.